Welcome to our dedicated page for Marex Group SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Marex Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Marex Group's regulatory disclosures and financial reporting.
Marex Group plc, a U.K.-based financial services firm, has filed its annual Form 20‑F, reporting under IFRS Accounting Standards and listing 72,937,470 ordinary shares outstanding as of year end. The company’s ordinary shares, par value $0.001551, trade on the NASDAQ Global Select Market under the symbol MRX.
The report emphasizes extensive risk factors tied to commodity market volatility, geopolitical events, interest and foreign exchange rates, client and counterparty defaults, and global regulatory complexity. Marex highlights operational and cybersecurity risks, including past cyber incidents at key vendors, growing use of artificial intelligence tools, and exposure to cryptocurrencies through derivatives and structured products.
Additional risks include climate‑change impacts on commodity markets, intense competition, challenges in recruiting and retaining key brokers, litigation and arbitration exposure, dependence on exchange memberships and clearing infrastructure, and integration and due‑diligence risks from an acquisitive growth strategy. As a foreign private issuer, Marex follows less frequent U.S. reporting requirements and warns that identified material weaknesses in internal control over financial reporting could affect the reliability and timing of future financial statements.
Marex Group plc director Robert Mark Pickering has reported beneficial ownership of 29,696 Ordinary Shares. This total includes 2,787 shares underlying restricted share awards that give him a contingent right to receive one ordinary share per award upon vesting and settlement.
Marex Group plc director files initial ownership report showing beneficial ownership of 24,095 Ordinary Shares. This total includes 2,787 shares underlying restricted share awards previously granted, each award representing a contingent right to receive one Ordinary Share upon vesting and settlement.
Marex Group plc executive Thomas Texier, Group Head of Clearing, reported beneficial ownership of 257,085 Ordinary Shares in an initial Form 3 filing. This total includes 192,348 shares underlying deferred bonus plan awards, which are contingent rights that may convert into ordinary shares upon vesting and settlement.
Marex Group plc director John W. Pietrowicz has filed an initial ownership report showing 22,259 Ordinary Shares. This figure represents his direct holdings as reported in the Form 3. The amount includes 2,787 shares tied to restricted share awards, which are contingent rights that convert into ordinary shares only upon vesting and settlement of the awards.
Marex Group plc filed an initial insider report for Nilesh Jethwa, CEO of Marex Solutions, showing his current equity position. The filing lists beneficial ownership of 287,015 Ordinary Shares.
This total includes 195,565 shares tied to deferred bonus plan awards previously granted to him. Each of these awards represents a contingent right to receive one ordinary share upon vesting and settlement, so part of his reported holding depends on future vesting conditions being met.
Marex Group plc director Linda Kristine Myers has filed an initial statement of beneficial ownership, reporting 22,259 ordinary shares held directly. This total includes 2,787 shares underlying restricted share awards, each representing a contingent right to receive one ordinary share upon vesting and settlement.
Marex Group plc director and Chief Financial Officer Irvin Rob filed an initial ownership report showing beneficial ownership of 38,104 ordinary shares. This total includes 32,443 shares tied to deferred bonus plan awards, which are contingent rights that only convert into ordinary shares when the awards vest and settle.
Marex Group plc director Ing Sarah has filed an initial Form 3 showing her ownership of the company’s ordinary shares. She reports 10,135 ordinary shares held directly, which include 2,787 shares underlying previously granted restricted share awards that may settle into ordinary shares upon vesting. She also reports 535 ordinary shares held indirectly through her spouse.